Get the Daily Brief
Latest Biotech News
Belite Bio Completes Phase 3 DRAGON Trial for Stargardt Disease Candidate
Belite Bio announced completion of the final subject visit in its two-year, Phase 3 DRAGON clinical trial evaluating Tinlarebant for Stargardt disease type 1, a degenerative retinal disorder with...
Nanomedicine Emerges as Strategy for Targeting Metastatic Cancer
The field of nanomedicine is providing new drug delivery approaches to address metastatic cancer, a leading cause of mortality. By utilizing nanoscale formulations, researchers aim to improve...
AI Boosts Peptide Therapeutics with Novel Drug Designs and Sustainability Concerns
Researchers report that AI-designed peptides are revolutionizing drug discovery by rapidly generating candidates that were previously unimagined. These advances, highlighted by experts including...
Lila Sciences Raises $300M to Advance Autonomous Science
Lila Sciences is nearing a massive Series A funding round exceeding $300 million, as reported exclusively by Endpoints News. The company aims to back its vision of building "scientific...
Biopharma Financing Trends Mark Strong Growth in 2025
The biopharma sector continues to attract substantial investment, with year-to-date financing data showing robust public and private capital influx. Notably, companies like Goodpath secured $18...
Novel Insights Advance Alzheimer’s and Neurodegeneration Research
Cutting-edge studies unveil new mechanisms pertinent to Alzheimer’s disease and related neurodegenerative conditions. Aarhus University researchers identified defects in exosome production linked...
Breakthrough Antibiotics and Natural Products Unearthed via Long-Read Sequencing
Rockefeller University researchers have pioneered terabase-scale long-read sequencing of soil metagenomes to unveil novel bioactive molecules, including two new antibiotic leads. This...
Advances in Cancer Therapeutics and Biomarker Identification
Recent developments include promising clinical and preclinical data shaping oncology treatments. Avidity Biosciences disclosed early and midstage trial results for del-zota, showing reversal of...
Bioprocessing and Lab Technology Innovations Gain Momentum
Further advances have emerged in bioprocessing and laboratory digitalization. Eppendorf launched the VisioNize box 2, enhancing lab device connectivity and cloud-based monitoring for improved...
Regulatory and Industry Shifts Impact Pharma Investments in UK
Pharmaceutical giants continue to reconsider investments in the UK amid evolving market conditions. AstraZeneca paused a $271 million expansion at its Cambridge research site, following similar...
FDA and Vaccine Safety Data Stir Public Health Debate
The FDA plans to present data alleging 25 child deaths linked to COVID-19 vaccines at an upcoming CDC advisory meeting. The analysis leverages VAERS, a self-reported database, which experts...
AI and Machine Learning Accelerate Drug Discovery and Diagnostics
The application of AI in biotechnology continues to deepen, exemplified by multiple initiatives. VedaBio licensed critical CRISPR IP from Mammoth Biosciences, enhancing its amplification-free...
Merck Exits UK, Spotlights Policy Concerns Amid US Growth
Merck has announced its exit from research and development activities in the United Kingdom, citing concerns about the country's life sciences policies. This move comes as Merck simultaneously...
Avidity and Remynd Report Positive Data in Rare and Neurodegenerative Diseases
Avidity Biosciences announced encouraging early and mid-stage trial results for del-zota, an antibody-oligonucleotide conjugate addressing Duchenne muscular dystrophy (DMD). Patients treated...
LPHCs Fundraise Big as Biotech Startups Gain Momentum
Lila Sciences is reportedly nearing a Series A funding round exceeding $300 million to advance autonomous scientific discovery using AI, while Goodpath secured $18 million for its chronic...
Soil Metagenome Sequencing Uncovers Novel Antibiotics and Microbial Diversity
Researchers at Rockefeller University have harnessed terabase-scale long-read sequencing technologies to unravel complex soil microbial genomes, which are largely uncultivable in laboratory...
FDA Biosimilars Adoption Faces PBM Barriers despite Significant Savings
A recent report highlights that biosimilars approved by FDA have generated over $56 billion in savings since 2015, yet their market adoption remains uneven across therapeutic areas. Pharmacy...
AI Peptide Design and Protein Therapeutics Gain Research Momentum
AI and machine learning are revolutionizing peptide and protein drug development. Professor Peter ‘t Hart highlights breakthroughs in sustainable peptide synthesis powered by AI-designed molecules...
Ultima Genomics and Sapio Sciences Partner to Streamline Multiomics Workflows
Ultima Genomics and Sapio Sciences have formed a strategic partnership integrating Sapio’s AI-driven lab informatics with Ultima’s high-throughput, low-cost sequencing platform. This collaboration...
Nanomedicine and Targeted Drug Delivery Advance Cancer Therapeutics
Researchers continue to innovate in nanomedicine to overcome obstacles in targeting metastatic cancer. New advancements include poly-L-histidine-coated mesoporous silica nanoparticles designed for...